Regonat 40® Regorafenib Tablets
Cancer (Oncology)

Regonat 40® Regorafenib Tablets

Regorafenib 40mg

Composition
Regorafenib 40mg
Dosage form
Tablet
Pack size
Bottle of 28 Tablet
Manufacturer
Natco
Also known as
Stivarga

Supplied against a valid prescription where required, in line with the regulations of the destination country.

Regonat 40 mg contains regorafenib, a targeted anticancer medicine used to treat certain advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma (liver cancer) after specified prior treatments.

Licensed wholesalerForm 20B & 21B, Delhi
Discreet packagingPlain outer box, no product labels
Worldwide shippingDirect to you or your customer

Related products

Call WhatsApp Request a Quote